Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing safety, Efficacy, and Pharmacokinetics of Miricorilant for schizophrenia.
Multiple locations, including BentonvilleThis study is completed in the United States. It is testing SAGE-217 for depression.
Multiple locations, including Little RockThis study is completed in Austria, in Germany, in Spain, .... It is testing Effect of ALKS 3831 Compared to Olanzapine on Body Weight for schizophrenia.
In AustriaThis study has public registry information in Germany. It is testing effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and for Bipolarity.
In GöttingenThis study is completed in the United States, in France, in Bulgaria, .... It is testing Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo for Bipolarity.
Multiple locations, including ScottsdaleThis study is completed in the United States. It is testing armodafinil Treatment for depression.
Multiple locations, including BirminghamThis study is completed in the United States, in Greece, in Lithuania, .... It is testing Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity.
Multiple locations, including CerritosThis study is completed in China, in Colombia, in Germany, .... It is testing risperidone for Bipolarity.
Multiple locations, including BaodingThis study is completed in Japan. It is testing Efficacy of FK949E for depression.
Multiple locations, including Aichi
This study has public registry information in China. It is testing Efficacy of VR for Bipolarity.
In ShanghaiThis study is completed in Global. It is testing sublingual Asenapine for schizophrenia.
In GlobalThis study is completed in the United States. It is testing Pharmacokinetics, Safety, and Tolerability of ABBV-932 for anxiety.
Multiple locations, including Los Alamitos